# PREVENTION OF WORSENING RENAL FUNCTION OF INTRAVENUS ALBUMIN IN HEART FAILURE PATIENTS

> **NCT06630923** · PHASE3 · RECRUITING · sponsor: **Democritus University of Thrace** · enrollment: 250 (estimated)

## Conditions studied

- Diuretics Drug Reactions
- Heart Failure; With Decompensation
- Albumin; Double

## Interventions

- **DRUG:** Human albumin

## Key facts

- **NCT ID:** NCT06630923
- **Lead sponsor:** Democritus University of Thrace
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-14
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-12-11
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2024-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06630923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06630923, "PREVENTION OF WORSENING RENAL FUNCTION OF INTRAVENUS ALBUMIN IN HEART FAILURE PATIENTS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06630923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*